Mark D. Fischer-Colbrie
President, Chief Executive Officer
Mr. Fischer-Colbrie was named President and CEO in September 2008 after working for one year as a business development consultant for the company. He has over 30 years of experience in companies in the areas of diagnostics, medical devices, therapeutics and high technology and has been involved in three Initial Public Offerings. Prior to joining Labcyte, Mr. Fischer-Colbrie was Senior Vice President of Finance and Administration and Chief Financial Officer at Adeza Biomedical Corporation, a women’s health care company, which became public in December 2004 and was subsequently sold for over $450 million. During his tenure from February 2001 to May 2007, Mr. Fischer-Colbrie was inventor and co-inventor on five patent applications and ran the Business Development function for three years. Prior that role, Mr. Fischer-Colbrie was the Senior Vice President, Finance and Administration and Chief Financial Officer for nearly nine years for KeraVision, Inc., a vision correction company. At Maxtor Corporation, a manufacturer of disk drives that grew from a start-up to $1.2 billion in revenue, he held several positions from April 1983 to February 1992 including Vice-President, Finance, Corporate Controller and Advanced Technology Business Manager.
Mr. Fischer-Colbrie holds a BA from Stanford University and an MBA in Marketing and Finance from the University of California at Berkeley. He has served in numerous roles for the Juvenile Diabetes Research Foundation and is currently on the Executive Board for the Greater Bay Area. He is also a member of committees of the JDRF International Board as well as part of the JDRF National Speaker's Program. Mr. Fischer-Colbrie is a board member of the Analytical Life Science Systems Association (ALSSA).
Richard Ellson
Chief Technology Officer
Mr. Ellson is a founder of Labcyte (formerly Picoliter Inc.) Previously, he was an Area Manager in novel printing technologies at the Xerox Palo Alto Research Center (PARC). Prior to PARC, he was at the Eastman Kodak Company in a variety of management and technical roles in the fields of color printing, image data compression, fluid handling, materials transport and net-shape manufacturing applications. His contributions to internal manufacturing processes were acknowledged by a Kodak Doctoral Award in 1988. Mr. Ellson was nominated for the 1994 Lemelson-MIT Prize and is the inventor on more than 60 issued U.S.and international patents. He received the 2006 PolyPops Foundation Award by the Society for Biomolecular Sciences for his role in developing acoustic dispensing technology, the basis for the Labcyte Echo liquid handlers.
Mr. Ellson holds a B.S. in Fluid and Thermal Science and a M.S. in Mechanical Engineering from Case Western Reserve University. Through the Kodak Doctoral Awards Program, he took a two-year paid leave to study mathematics at the University of Illinois at Urbana-Champaign.
Stephen Bates
Senior Vice President of Sales, Support and Marketing
Mr. Bates joined Labcyte in June 2008. He had previously served as Executive Vice President, MetaMorphix, Inc. and General Manager of MMI Genomics since February 2002 as part of MetaMorphix's acquisition of Celera AgGen's anmial business. Mr. Bates established PE AgGen in 1994 and it became a world leader in its field of genomic research in agriculture. AgGen became part of Celera in 1999, and he was named Vice President of Celera Genomics and General Manager of Celera AgGen in 1999. Mr. Bates joined Applied Biosystems in 1987 in Warrington, UK. He was named DNA Market Manager for Europe in 1989, and in 1992, became European Marketing Manager with responsibility for the planning, development, and execution of marketing policies through Applied Biosystems' direct subsidiaries and its distributors. Prior to that, he was a Research Officer at the department of Biochemistry at Queen's University, Belfast. Mr. Bates received his bachelor's degree in microbiology in 1979 and his master's degree in biochemistry in 1983 from Queen's University, Belfast.
Keith Love
Vice President, Manufacturing
Mr. Love has over 25 years of leadership experience in a variety of technology companies, including biotech, telecom, specialty materials, equipment, and semiconductor. He has successfully managed both start up and turn-around situations. Mr. Love was most recently General Manager/Vice President of Operations at InLight Communications, a telecom start up developing optical MEMS solutions. Prior to that, Mr. Love was Vice President of Operations for Synteni, a biotech start up that merged with Incyte Genomics. Prior to Synteni, he spent eight years as General Manager for Heraeus, a leading supplier to semiconductor equipment manufacturers and end users, where he had overall responsibility for their largest and most profitable division. Mr. Love has a B.S. in Mechanical Engineering from the University of Illinois at Urbana-Champaign.
Michael F. Miller
Vice President, Product Development
Mr. Miller has over 30 years of experience in engineering and management. Previous to joining Labcyte , he was Department Director, Genomics Systems Development and a member of Amersham Biosciences Sunnyvale site senior management team. During his tenure at Molecular Dynamics, which was acquired by Amersham, he held several other positions including Director, Product Development and Director of Mechanical Engineering. He was instrumental in the successful introduction of a variety of products including the PhosphorImager®, FluorImager® and Storm™ imaging systems and the MegaBACE® DNA sequencer. Prior to Molecular Dynamics, he held various management and technical positions at Spectra Physics. Mr. Miller is an inventor on six U. S. patents and holds a B.S. in Mechanical Engineering from San Jose State University.
Tammy L. Cameron, CPA
Vice President, Finance
Ms. Cameron has been our Vice President of Finance since December 2011. Ms. Cameron has over 20 years of accounting and commercial financial expertise in public and private companies. From January 2009 to December 2011, she served as Vice President of Finance at DepoMed Inc. and from July 2007 to January 2009 as Controller. Ms. Cameron was Controller of Adeza Biomedical Corporation from January 2005 to June 2007 and helped in its IPO process and subsequent sale. From 2001 to 2005, Ms. Cameron was Director of Finance and Administration of Timi3 Systems. Prior to Timi3 Systems, Ms. Cameron was Director of Treasury and External Reporting of KeraVision, Inc. She served as a member of Ernst & Young's audit practice. She is a Certified Public Accountant and holds a B.A. degree from California State University, East Bay.